113
Views
14
CrossRef citations to date
0
Altmetric
Review

Stimuli-responsive polymers in gene delivery

Pages 501-509 | Published online: 09 Jan 2014

References

  • Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 270, 404–410 (1995).
  • Verma M, Somia N. Gene therapy – promises, problems and prospects. Nature 389, 239–242 (1997).
  • Cheng SH, Smith AE. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders. Gene Ther. 10, 1275–1281 (2003).
  • Hannon GJ. RNA interference. Nature 418, 244–251 (2002).
  • Pirolloa KF, Raita A, Sleerb LS, Chang EH. Antisense therapeutics: from theory to clinical practice. Pharmacol. Ther. 99, 55–77 (2003).
  • Shi F, Hoekstra D. Effective intracellular delivery of oligonucleotides in order to make sense of antisense. J. Control. Release 97, 189–209 (2004).
  • Wells JM, Li LH, Sen A et al. Electroporation – enhanced gene delivery in mammary tumors. Gene Ther. 7, 541–547 (2000).
  • Anwer K, Kao G, Proctor B et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7, 1833–1839 (2000).
  • Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12, 861–870 (2001).
  • Ndoye A, Merlin JL, Leroux A et al. Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes. J. Gene Med. 6, 884–894 (2004).
  • Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262, 4429–4432 (1987).
  • Kircheis R, Kichler A, Wallner G et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4, 409–418 (1997).
  • Ogris M, Brunner S, Schuller S et al. Pegylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6, 595–605 (1999).
  • Erbacher P, Bettinger T, Belguise-Valladier P. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1, 210–222 (1999).
  • Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 247, 1465–1468 (1990).
  • Zhang G, Vargo D, Budker V et al. Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers. Hum. Gene Ther. 8, 1763–1772 (1997).
  • St. George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther. 10, 1135–1141 (2003).
  • Kootstra NA, Verma IN. Gene therapy with viral vectors. Ann. Rev. Pharmacol. Toxicol. 43, 413–439 (2003).
  • Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346–358 (2003).
  • Nabel GJ, Nabel EG, Yang ZY et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression biologic activity and lack of toxicity in humans. Proc. Natl Acad. Sci. USA 90, 11307–11311 (1993).
  • Felgner PL, Gadek TR, Holm M et al. Lipofection – a highly efficient, lipidmediated DNA-transfection procedure Proc. Natl Acad. Sci. USA 84, 7413–7417 (1987).
  • Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235, 289–295 (1995).
  • Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2, 710–722 (1995).
  • Crook K, McLachlan G, Stevenson BJ, Porteous DL. Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Ther. 3, 834–839 (1996).
  • Porteous DJ, Dorin JR, McLachlan G et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 210–218 (1997).
  • Li B, Li S, Tan YD, Stolz DB et al. Lyophilization of cationic lipidprotamine-DNA (LPD) complexes. J. Pharm. Sci. 89, 355–364 (2000).
  • Serikawa T, Suzuki N, Kikuchi H et al. A new cationic liposome for efficient gene delivery with serum into cultured human cells: a quantitative analysis using two independent fluorescent probes. Biochim. Biophys. Acta 1467, 419–430 (2000).
  • Zou YY, Zong G, Ling YH, Perez-Soler R. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer. Cancer Gene Ther. 7, 683–696 (2000).
  • De Lima MCP, Neves S, Filipe A et al. Cationic liposomes for gene delivery: from biophysics to biological applications. Curr. Med. Chem.10, 1221–1231 (2003).
  • De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharma. Res. 17, 113–126 (2000).
  • Brown MD, Schatzlein AG, Uchegbu IF. Gene delivery with synthetic (non-viral) carriers. Int. J. Pharm. 229, 1–21 (2001).
  • Niidome T, Huang L. Gene therapy progress and prospects: non-viral vectors. Gene Ther. 9, 1647–1652 (2002).
  • Merdan M, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev.54, 715–758 (2002).
  • Cho YW, Kim JD, Kinam Park K. Polycation gene delivery systems: escape from endosomes to cytosol. J. Pharm. Pharmacol. 55, 721–734 (2003).
  • Jeong JH, Song SH, Lim DW et al. DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). J. Control. Release 73, 391–399 (2001).
  • Fischer D, Zange R, Kissel T. Comparative in vitro cytotoxicity studies of polycation for gene therapy. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 24, 527–528 (1997).
  • Fischer D, Bieber T, Elasser HP, Kissel T. Polyethylenimine synthesis and in vitro cytotoxicity of a low molecular weight polycation for gene transfer. Eur. J. Cell. Biol. 75, 108–116 (1998).
  • Fischer D, Bieber T, Elasser HP, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethleneimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 16, 1273–1279 (1999).
  • Choksakulnimitr S, Masuda S, Takuda H et al. In vitro cytotoxicity of macromolecules in different cell culture systems. J. Control. Release 34, 233–241 (1995).
  • Richardson SCW, Kolbe HVJ, Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178, 231–243 (1999).
  • Hwang S, Bellocq N, Davis ME. Effects of structure of β-cyclodextrin-containing polymers on gene delivery. Bioconjug Chem.12, 280–290 (2001).
  • Han SO, Mahato RI, Sung YK, Kim SW. Development of biomaterials for gene therapy. Mol. Ther. 2, 302–317 (2000).
  • Cohen H, Levy RJ, Gao J et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7, 1896–1905 (2000).
  • Plank C, Mechtler K, Szoka F, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7, 1437–1446 (1999).
  • Wang D, Robinson DR, Kwan GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Control. Release 57, 9–18 (1999).
  • Harvie P, Wong FMP, Bally MB. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J. Pharm. Sci. 89, 652–663 (2000).
  • Galaev IY, Mattiasson B. Smart polymers and what they could do in biotechnology and medicine. Trends Biotech. 17, 335–340 (1999).
  • Kost J, Langer R. Responsive polymeric delivery systems. Adv. Drug Deliv. Rev.46, 125–148 (2001).
  • Jeong B, Gutowska A. Lessons from nature: stimuli-responsive polymers and their biomedical applications. Trends Biotech. 27, 305–311 (2002).
  • Shimoboji T, Larenas E, Fowler T, Kulkarni S, Hoffman AS, Stayton PS. Photoresponsive polymer-enzyme switches. Proc. Natl Acad. Sci. USA 99, 16592–16596 (2002).
  • Yokoyama M. Gene delivery using temperature-responsive polymeric carriers. Drug Discov. Today 7, 426–432 (2002).
  • Hinrichs WLJ, Schuurmans-Nieuwenbroek NME, De Wetering PV, Hennink WE. Thermosensitive polymers as carriers for DNA delivery. J. Control. Release 60, 249–259 (1999).
  • Kurisawa M, Yokoyama M, Okano T. Gene expression control by temperature with thermo-responsive polymeric gene carriers. J. Control. Release 68, 1–8 (2000).
  • Kurisawa M, Yokoyama M, Okano T. Transfection efficiency increases by incorporating hydrophobic monomer units into polymeric gene carriers. J. Control. Release 69, 127–137 (2000).
  • Nagasaki T, Atarashi K, Makino K et al. Synthesis of a novel water-soluble polyazobenzene dendimer and photoregulation of affinity towards DNA. Mol. Cryst. Liq. Cryst. 345, 227–232 (2000).
  • Twaites BR, Alarcon CH, Cunliffe D et al. Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro. J. Control. Release 97, 551–566 (2004).
  • Dinçer S, Tuncel A, şPiskin E. A potential gene delivery vector: N-Isopropylacrylamide-ethyleneimine block co-polymers. Macromol. Chem. Phys. 203, 1460–1465 (2002).
  • Zareie MH, Dinçer S, şPiskin E. Observation of phase transition of thermo-responsive poly(NIPA)-PEI block co-polymers by STM, J. Coll. Interface Sci. 251, 424–428 (2002).
  • Pisşkin E. Molecularly designed water soluble, intelligent, nanosize polymeric carriers. Int. J. Pharm. 277, 105–118 (2004).
  • Pisşkin E, Dinçer S, Türk M. Gene delivery-intelligent but just at the beginning. J. Biomater. Sci. Polym. Ed. 15, 1181–1202 (2004).
  • Türk M, Dinçer S, Yuluğ IG, şPiskin E. In vitro tansfection of HeLa cells with stimuli-responsive and polycationic co-polymers. J. Control. Release 96, 325–340 (2004).
  • Türk M, Dinçer S, şPiskin E. In vitro transfection of smooth muscle cells with temperature sensitive smart polymers. Gene Ther. (2004) (In Press).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.